What's new

Orphan designation: Trehalose Treatment of neuronal ceroid lipofuscinosis, 19/10/2020 Withdrawn

Orphan designation: Trehalose Treatment of neuronal ceroid lipofuscinosis, 19/10/2020 Withdrawn

Mar 12, 2025 - 17:13
 0
Orphan designation: Trehalose Treatment of neuronal ceroid lipofuscinosis, 19/10/2020 Withdrawn
Orphan designation: Trehalose Treatment of neuronal ceroid lipofuscinosis, 19/10/2020 Withdrawn
Read More

Tags:

Previous Article

AbbVie regained TV ad spending lead amid February slowdown, with Rinvoq and Skyr...

Next Article

Orphan designation: Humanised IgG4 monoclonal antibody against C1q Treatment of ...

Related Posts

Orphan designation: hydroxocobalamin acetate Treatment of homocystinuria and/or methylmalonic acidaemia due to genetic defects of intracellular cobalamin processing, 26/02/2025 Positive

Orphan designation: hydroxocobalamin acetate Treatment ...

Mar 11, 2025  0

Good distribution practice

Good distribution practice

Feb 24, 2025  0

Veterinary medicines European public assessment report (EPAR): Poulvac Procerta HVT-IBD-ND , Live recombinant turkey herpes virus, strain HVT-IBD-ND, expressing the VP2 protein of IBDV and the F protein of NDV, Status: Authorised

Veterinary medicines European public assessment report ...

Feb 24, 2025  0